The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
To test whether the hypothesis that the Alzheimer's A beta peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that A beta is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While evidence for extracellular Aβ deposition was scarce, neuronal Aβ immunoreactivity was detected in the cortex and hippocampus, resulting in abundant neurodegeneration, with biochemical and morphological evidence for an apoptotic mechanism [61].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [61]
In the citing paper
“Efficient secretion of Aβ from the BRI fusion protein distinguishes this approach from studies using Aβ minigene constructs that generate high levels of intracellular Aβ and minimal secreted Aβ (LaFerla et al., 1995).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“However, none of these studies prove or disprove a role of intracellular Aβ in AD pathogenesis.”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“Previous studies with transgenic mice expressing Aβ minigenes that are not efficiently secreted suggest that intracellular Aβ can be neurotoxic (LaFerla et al., 1995), as do studies of direct injection of aggregated Aβ into cultured primary neurons (Zhang et al., 2002).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“lack of plaque formation in intraneuronal Aβ42 accumulating transgenic mice with concomitant neurodegeneration [36, 93] limited conclusions that could be drawn to the human disease, since pathological diagnosis of AD requires Aβ plaques.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [93]
Citations
Cites
1 retracted
Kawabata, S., Higgins, G. A., & Gordon, J. W. (1991) · Nature · doi:10.1038/354476a0 · Cited by 108
RetractedIdentification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Research works printed but not linked: 2
- Wyllie, A.H. Cell death. Int. Rev. Cytol. S17, 755–785 (1987).
- Kim, K.S. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Comm. 2, 121–130 (1988).
Cited by
Items 401–500 of 511
Apoptosis in Neurodegenerative Disorders
Schmechel, D. E. (1998) · Frontiers in neuroscience · doi:10.1201/9781420048490.ch3 · Cited by 10
Oxidative Stress in Alzheimer’s Disease
Ceballos-Picot, I. (1997) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22516-5_5 · Cited by 10
Transgenic mice in amyloid research: an interpretive review
Teng, M.-H., & Buxbaum, J. N. (1996) · Amyloid · doi:10.3109/13506129609045521 · Cited by 12
Recent advances in transgenic model development for Alzheimer's disease
Sommer, B. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.12.2017 · Cited by 10
Use of brain grafts to study the pathogenesis of prion diseases
Aguzzi, A., Klein, M. A., Musahl, C., Raeber, A. J., Blättler, T., Hegyi, I., Frigg, R., & Brandner, S. (1998) · Essays in Biochemistry · doi:10.1042/bse0330133 · Cited by 9
A Human Embryonic Stem Cell Model of Aβ-Dependent Chronic Progressive Neurodegeneration
Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01007 · Cited by 9
Tracking prions: the neurografting approach
Aguzzi, A., Bl�ttler, T., Klein, M. A., R�ber, A. J., Hegyi, I., Frigg, R., Brandner, S., & Weissmann, C. (1997) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050060 · Cited by 9
Strategies to alter the progression of Alzheimer's disease
Siman, R. G., & Scott, R. W. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80070-x · Cited by 9
Familial Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: Transgenic Models
Wong, P. C., Borchelt, D., Lee, M. K., Pardo, C. A., Thinakaran, G., Martin, L. J., Sisodia, S. S., & Price, D. L. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_9 · Cited by 8
Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice
Ali, S. M., Siedlak, S. L., Gonzalez‐DeWhitt, P. A., Altman, R. A., Glendening, J. M., Lowery, D. E., Savage, M. J., Polities, H. G., Perry, G. L., & Greenberg, B. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02065-9 · Cited by 8
Wang, X., Li, B., Yu, X., Zhou, Y., Wang, K., & Gao, Y. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13139 · Cited by 8
NREM sleep loss increases neurofilament light chain levels in APP/PS1 and C57BL/6 J mice
Liu, S., Zhang, Z., Shi, S., Meng, Y., Zhang, X., Lei, Q., & Li, Z. (2022) · Sleep And Breathing · doi:10.1007/s11325-022-02719-7 · Cited by 8
Volpina, O. M., Volkova, T. D., Titova, M. A., Gershovich, Y. G., Medvinskaya, N. I., Samokhin, A. N., Kamynina, A. V., Shalgunov, V., Koroev, D. O., Филатова, М. П., et al. (2008) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162008010056 · Cited by 7
Li, H., Wu, X., Chen, T., Jiang, X., & Ren, C. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.06.024 · Cited by 7
From prion diseases to Alzheimer’s disease
Hsiao, K. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_15 · Cited by 8
Transgenic mice: What are we learning about gene function and neurological disease?
Longo, F. M. (1995) · The Neuroscientist · doi:10.1177/107385849500100601 · Cited by 7
Amyloid β peptide binds a novel death‐inducing protein, AB‐DIP
Lakshmana, M. K., Araki, W., & Tabira, T. (2005) · The FASEB Journal · doi:10.1096/fj.05-3672fje · Cited by 9
Alzheimer’s disease: transgenic mouse models and drug assessment
Yu, P., & Oberto, G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0670 · Cited by 8
Aβ degradation—the inside story
Leissring, M. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00229 · Cited by 7
Tolar, M., Scott, S. A., & Crutcher, K. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01455-8 · Cited by 6
Partial characterization of apoptotic factor in Alzheimer plasma
Maesaka, J. K., Palaia, T. A., Chowdhury, S. A., Shimamura, T., Fishbane, S., Reichman, W. E., Coyne, A. C., O’Rear, J. J., & El-Sabban, M. E. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.4.f521 · Cited by 6
Vogt, B. A., Vogt, L. J., & Hof, P. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50012-3 · Cited by 6
Nutrition and Alzheimer's Disease
Folstein, M. F. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1997.tb06118.x · Cited by 9
Hsiao, K. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_3 · Cited by 6
Establishment of a Murine Model for Metastasis of Cytokine‐Producing Tumor to the Brain
Nakai, M., Takauchi, S., Yamaguchi, T., Kawamata, T., Maeda, K., & Tanaka, C. (1997) · Pigment Cell Research · doi:10.1111/j.1600-0749.1997.tb00690.x · Cited by 5
How to Stabilize Both the Proteins and the Membranes: Diverse Effects of sHsps in Neuroprotection
Tóth, M. E., Sántha, M., Penke, B., & Vígh, L. (2015) · Heat shock proteins · doi:10.1007/978-3-319-16077-1_23 · Cited by 6
PheSeq, a Bayesian deep learning model to enhance and interpret the gene-disease association studies
Yao, X., Ouyang, S., Lian, Y., Peng, Q., Zhou, X., Huang, F., Hu, X., Shi, F., & Xia, J. (2024) · Genome Medicine · doi:10.1186/s13073-024-01330-7 · Cited by 5
Lymphoblastoid cell lines of Rett syndrome patients exposed to oxidative-stress-induced apoptosis
Battisti, C., Formichi, P., Tripodi, S. A., Meloni, I., Mangiavacchi, P., Zappella, M., & Federico, A. (2004) · Brain and Development · doi:10.1016/j.braindev.2003.12.001 · Cited by 9
John, P. A. S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21251 · Cited by 7
Observations on Early Development of the Murine Fetal Oral Vestibule
Jae-Goo, K. I. M., IWAI-LIAO, Y., & Higashi, Y. (1998) · Okajimas Folia Anatomica Japonica · doi:10.2535/ofaj1936.75.2-3_131 · Cited by 5
Multifocal Cortical Neurodegeneration in Alzheimer’s Disease
Vogt, B. A., Martin, A. D., Vrana, K. E., Absher, J. R., Vogt, L. J., & Hof, P. R. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_16 · Cited by 5
Potassium Channels in Neuropsychiatric Disorders: Potential for Pharmacological Intervention
Allen, J. W., & Etcheberrigaray, R. (1998) · CNS Drugs · doi:10.2165/00023210-199810010-00005 · Cited by 5
The β-Amyloid Model of Alzheimer’s Disease
Cotman, C. W., Cribbs, D. H., & Anderson, A. J. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_6 · Cited by 5
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 8
Amyloid Hypothesis and Alzheimer's Disease
Sun, X., & Zhang, Y. (2011) · InTech eBooks · doi:10.5772/28947 · Cited by 4
Enhancing imaging depth by multi-angle imaging of embryonic structures
Sudheendran, N., Wu, C., Dickinson, M. E., Larina, I. V., & Larin, K. V. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2045529 · Cited by 4
Effects of Heredity on Response to Drugs and Environmental Chemicals: Construction of Rodent Models
Levy, G. N., Rodgers, L., & Weber, W. W. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960082y · Cited by 4
The Role of Proteases in Neuronal Apoptosis
Kaufmann, S. H., & Mesner, P. W. (1998) · Frontiers in neuroscience · doi:10.1201/9781420048490.ch6 · Cited by 4
Alzheimer's disease: Mechanisms and development of therapeutic strategies
Tabira, T. (2003) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1444-1586.2003.00082.x · Cited by 3
Salemi, M., Giuffrida, D., Giuffrida, M. C., Soma, P. F., Vignera, S. L., Cimino, L., Condorelli, R. A., Romano, C., Bosco, P., Vicari, L. O., et al. (2012) · The International Journal of Biological Markers · doi:10.5301/jbm.2012.8991 · Cited by 3
Kaczanowski, S. (2020) · Results and problems in cell differentiation · doi:10.1007/978-3-030-51849-3_10 · Cited by 4
Fischer, K. M. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90200-0 · Cited by 3
Pathology, Neurobiology, and Animal Models of Alzheimer's Disease
Sisodia, S. S., Price, D. D., Crain, B. J., & Troncoso, J. C. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch12 · Cited by 3
Leissring, M. A., & Saido, T. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_10 · Cited by 3
Transgenic mice in apoptosis research
Gil‐Gómez, G., & Brady, H. J. M. (1998) · APOPTOSIS · doi:10.1023/a:1009607121302 · Cited by 3
Bai, J. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2007.12.016 · Cited by 3
Induction of Apoptosis after Stent Implantation in Canine Portal Vein
Kudo, F. A., Nishibe, T., Miyazaki, K., Watanabe, S., Flores, J. A., & Yasuda, K. (2002) · Annals of Vascular Surgery · doi:10.1007/s10016-001-0085-9 · Cited by 3
Bengtsson, S. K. S. (2013) · DiVA at Umeå University (Umeå University) · Cited by 4
A History of the Morphology of Alzheimer’s Disease
Terry, R. D. (2019) · CRC Press eBooks · doi:10.1201/9780429260353-5 · Cited by 3
Incidence of Apoptosis and Its Pathological and Biochemical Manifestations
Cameron, R., & Feuer, G. M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57075-9_1 · Cited by 3
Heat Shock Proteins, Unfolded Protein Response Chaperones and Alzheimer’s Disease
Magrané, J., & Querfurth, H. W. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8231-3_2 · Cited by 3
Hayann, L., de Melo, M. T., Nogueira, L. F. B., Ciancaglini, P., Bottini, M., & Ramos, A. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99158-2.00013-9 · Cited by 3
On the origins and evolution of apoptosis: the predator–mitochondrial prey hypothesis
Zielenkiewicz, U., Kaushal, V., & Kaczanowski, S. (2025) · Journal of Evolutionary Biology · doi:10.1093/jeb/voaf039 · Cited by 3
Glia inflammation and cell death pathways drive disease progression in preclinical and early AD
Woo, M. S., Therriault, J., Hosseini, S. A., Wang, Y.-T., Macedo, A. C., Rahmouni, N., Aumont, É., Servaes, S., Tissot, C., Arias, J. F., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00316-1 · Cited by 7
Free Cholesterol — A Double-Edge Sword in Alzheimer Disease
Fernández-Checa, J. C. (2015) · InTech eBooks · doi:10.5772/59935 · Cited by 3
Designing Animal Models of Alzheimer's Disease with Amyloid Precursor Protein (APP) Transgenes
Loring, J. F. (2003) · Humana Press eBooks · doi:10.1385/1-59259-195-7:249 · Cited by 2
Immunotherapy in Alzheimer’s Disease
Gupta, J., & Hoque, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_14 · Cited by 2
Analysis of neuronal death in the central nervous system using a new apoptosis model
Okura, Y., Tanaka, R., Ono, K., Yoshida, S., & Watanabe, T. (1996) · Neuroscience Research · doi:10.1016/s0168-0102(96)01107-8 · Cited by 3
Neurotoxic Oxidative Metabolite of Serotonin
Volicer, L., Wrona, M. Z., Matson, W. R., & Dryhurst, G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_8 · Cited by 2
Alzheimer disease models and human neuropathology: similarities and diVerences
Duyckaerts, C. J., Potier, M., & Delatour, B. (2008) · Cited by 2
Signaling by β-Amyloid Precursor Protein
Furukawa, K. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-475-7_11 · Cited by 2
Soleymaninejadian, E., & Dehkordi, M. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619456 · Cited by 2
Place cell physiology in a transgenic mouse model of Alzheimer's disease
Yi, M. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Recent progress in the study of intracellular toxicity of amyloid β peptide in Alzheimer's disease
Zhang, Y., & Yu, L. (2007) · Progress in Natural Science Materials International · doi:10.1080/10020070612331343253 · Cited by 1
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Genetically Engineered Mouse Models of Neurodegenerative Disorders
Masliah, E., & Crews, L. A. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_19 · Cited by 1
Apoptosis in Neurodegenerative Diseases
Liang, Q., & Zhang, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_21 · Cited by 1
Neuronal cell death by Alzheimer's disease-relevant insults and its rescue
Niikura, T., Hashimoto, Y., Tajima, H., Ito, Y., & Nishimoto, I. (2003) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.40.36 · Cited by 1
Genetically Engineered Models of Human Age-Related Neurodegenerative Diseases
Vickers, J. C. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50027-5 · Cited by 1
A human embryonic stem cell model of Aβ-dependent chronic progressive neurodegenerationPreprint
Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/419978 · Cited by 1
Metabolic Abnormalities in Alzheimer Disease
Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 2
A History of the Morphology of Alzheimer's Disease
Terry, R. D. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch3 · Cited by 1
Wei, Q., Liu, S., Yan, L. W., Zhuang, J., Li, J., Zhou, C., & Huang, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-5598577/v1 · Cited by 1
Telencephalic Brain Grafts in the Study of Scrapie Pathogenesis
Aguzzi, A., Blättler, T., Klein, M., Räber, A., & Brandner, S. (1998) · Springer eBooks · doi:10.1007/978-3-642-80403-8_18 · Cited by 1
A New Focus on Cytoskeletal Therapy in Alzheimer’s Disease
Geerts, H., Nuydens, R., de Jong, M., & Kieboom, G. V. D. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_10 · Cited by 2
Chapter 1 Amyloid and Amyloid-Like Protein Aggregates in Neurodegenerative Disease
Golde, T. E. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70052-8
Muthuswamy, A. (2008) · UKnowledge (University of Kentucky)
Intraneuronal Aβ and Alzheimer’s Disease
Billings, L. M., & LaFerla, F. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_31
Self-citationSisodia, S. S., Thinakaran, G., Lamb, B. T., Slunt, H. H., von Koch, C. S., Ginsberg, S. D., Lo, A., Lee, M. K., Roskams, A. J., Masliah, E., et al. (1996) · Springer eBooks · doi:10.1007/978-3-662-03248-0_4
Systemic Alterations of Soluble Fas in Alzheimer�s Disease
Richartz, E., Noda, S., G�nthner, A., Lewczuk, P., Wormstall, H., Buchkremer, G., Bartels, M., & Schott, K. J. (2001) · KARGER eBooks · doi:10.1159/000058887
Scrapie Pathogenesis in Brain Grafts
Aguzzi, A., & Brandner, S. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1896-3_19
Andersson, K. (2005) · DiVA at Umeå University (Umeå University)
Transgenic Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease
Wong, P. C., Borchelt, D., Lee, M. K., Thinakaran, G., Sisodia, S. S., & Price, D. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50008-7
Striving for useful phenotypes in β-APP transgenic mice
Higgins, L. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00079-t
Apolipoproteins and β Amyloid Transport Pathway
Kamino, K., Kida, T., Tanaka, T., Tanii, H., Okochi, M., Kudo, T., Kobayashi, T., & Takeda, M. (2002) · Psychogeriatrics · doi:10.1111/j.1479-8301.2002.tb00078.x
Merlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.3.143
Molina, M. A., & Jesús, A. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Roberson, E. D., & Palop, J. J. (2011)
Pathological Consequences of Aβ From Extracellular to Intraneuronal
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00004-8
ENRIQUECIMIENTO AMBIENTAL EN RATONES 3xTgAD
Alzheimer, M. D. (2011)
In Vivo Neurotoxicity of β-Amyloid 1–40 in the Rat Hippocampus
Miguel-Hidalgo, J. J., Álvarez, A., & Cacabelos, R. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_100
Protein Profiling of the Brain: Proteomics of Isolated Tissues and Cells
Haverland, N. A., & Ciborowski, P. (2012) · Neuromethods · doi:10.1007/978-1-61779-448-3_9
Albrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
Genetic animal models for Alzheimer's disease
Neve, R. L., Boyce, F. M., & Oster‐Granite, M. L. (1995) · Elsevier eBooks · doi:10.1016/b978-012437165-1/50014-7
Intraneuronal Ab and Alzheimer's Disease
Billings, L. M., & LaFerla, F. M. (2008)
Self-citationAN ISOGENIC STEM CELL MODEL OF ALZHEIMER'S DISEASE: DIRECT EXPRESSION OF AMYLOID-BETA
Ubina, T. (2017) · CSUSB ScholarWorks (California State University, San Bernardino)
Biochemie und Molekulargenetik 1995
Berchtold, H., Rudolph, R., Kiefhaber, T., Darlison, M. G., Breitenbach, U., Lübbert, H., Boddeke, H. W. G. M., & Blohm, D. H. (1996) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19960440209
Cognitive Deficits in Neurodegenerative Disorders: Parkinson’s Disease and Alzheimer’s Disease
Bodis-Wollner, I. G., & Moreno, H. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_9
Metadata
- Authors
- LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G.
- Venue
- Nature Genetics
- Published
- 1995-01
- Volume
- 9
- Issue
- 1
- Pages
- 21-30
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1992484817
- Cited by
- 513
- References
- 69
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 8 · 2020: 11 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 16 · 2014: 13 · 2013: 9 · 2012: 13
- FWCI
- 34.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, neurotoxicity, neuronal apoptosis, neurodegeneration, reactive gliosis, transgenic mice, neuronal loss
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Gliosis, Humans, Mice, Transgenic, Molecular Sequence Data, Nerve Degeneration, DNA Probes, Gene Expression, Amyloid beta-Peptides, Apoptosis, In Situ Hybridization, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.